查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586133

心血管针市场：按产品类型、应用、最终用户、应用 - 全球预测 2025-2030

Cardiovascular Needle Market by Product Type (Cutting Needles, Round Bodied Needles), Usage (Multiple Use Or Eyed Needles, Single Use Or Eyeless Needles), End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心血管针市场价值为8317万美元，预计2024年将达到8902万美元，复合年增长率为7.11%，预计2030年将达到13459万美元。

心血管针市场包括专为心血管手术设计的手术针，例如心血管手术、心血管修復和移植期间的缝合。这些针是必不可少的，因为它们在精緻和关键的手术环境中对精度、生物相容性和耐腐蚀性有独特的需求。心血管针的需求源于心血管疾病的日益流行以及由于人口老化和文明病等因素而导致全世界所需的外科手术数量不断增加。最终用途主要包括医院、专科诊所和门诊手术中心。影响市场成长的关键因素包括需要更可靠和高效工具的外科技术的进步、医疗基础设施的普及以及需要先进针技术的微创手术的采用增加。这个市场的机会在于减少手术时间和创伤的针的开发，以及提高性能的材料科学创新。机器人辅助手术的兴起将进一步推动对专用针头的需求，使这一领域的创新时机成熟。然而，严格的法律规范、先进手术针的高成本以及一次性性质限制了长期使用的盈利等挑战正在阻碍市场成长。此外，各地区医疗保健标准的差异是影响普遍采用的主要限制因素。因此，创新策略包括专注于具有成本效益的生产技术、开发生物分解性或可重复使用的针头，以及透过客製化产品扩展到新兴市场以克服地区差异。此外，正在进行的奈米材料和智慧技术研究为製造具有即时回馈感测器的下一代针提供了一个有前景的前沿。儘管市场仍然分散，但激烈的竞争是显而易见的，企业需要灵活地回应技术趋势和最终用户的需求，以有效地利用成长机会。

主要市场统计
基准年[2023] 8317万美元
预测年份 [2024] 8902万美元
预测年份 [2030] 13459万美元
复合年增长率（%） 7.11%

市场动态：揭示快速发展的心血管针市场的关键市场洞察

供需的动态交互作用正在改变心血管针市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球心血管治疗的增加
    • 老年人口不断增加，心血管疾病盛行率上升
    • 心臟直视手术数量增加
  • 市场限制因素
    • 使用手术钉代替针
  • 市场机会
    • 增加雷射钻孔和心血管针等技术干预措施
    • 医疗设备研发费用增加
  • 市场挑战
    • 医护人员受伤的风险

波特的五力：驾驭心血管针市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对心血管针市场的影响

外部宏观环境因素在塑造心血管针市场的业绩动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解心血管针市场竞争状况

心血管针市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心血管针市场供应商的绩效评估

FPNV 定位矩阵是评估心血管针市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了心血管针市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对心血管针市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球心血管干预措施不断增加
      • 老年人口增加，心血管疾病发生率上升
      • 心臟直视手术增加
    • 抑制因素
      • 使用手术钉代替针
    • 机会
      • 增加心血管针技术干预，包括雷射钻孔
      • 医疗设备研发成本增加
    • 任务
      • 医护人员的受伤风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心血管针市场：依产品类型

  • 剪断针
  • 圆针

第七章按应用分類的心血管针市场

  • 多功能或标记针
  • 一次性或无孔针

第八章心血管针市场：依最终用户分类

  • 门诊手术中心
  • 医院/诊所
  • 专科诊所

第九章心血管针市场：依应用分类

  • 心臟瓣膜手术
  • 冠状动脉绕道手术
  • 移植手术
  • 心臟移植
  • 心臟直视手术

第10章美洲心血管针市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太心血管针市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲心血管针市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Aurolab
  • B. Braun Melsungen AG
  • Barber of Sheffield Ltd.
  • Becton, Dickinson, and Company
  • CP Medical, Inc. by Theragenics Corporation
  • Delacroix-Chevalier
  • Johnson & Johnson Services, Inc.
  • KLS Martin, LP
  • MANI, Inc.
  • Medline Industries, LP
  • Meril Life Sciences Pvt. Ltd.
  • Quality Needles Pvt. Ltd.
  • Rumex International Corporation Ltd.
  • Scanlan International Inc.
  • Sklar Surgical Instruments
  • Surtex Instruments Limited
  • Suturex & Renodex
  • Symmetry Surgical Inc.
  • Teleflex Incorporated
  • Wexler Surgical
Product Code: MRR-CA17E905E9F5

The Cardiovascular Needle Market was valued at USD 83.17 million in 2023, expected to reach USD 89.02 million in 2024, and is projected to grow at a CAGR of 7.11%, to USD 134.59 million by 2030.

The cardiovascular needle market encompasses surgical needles specifically designed for cardiovascular procedures, including suturing during heart surgeries, cardiovascular repairs, and implantations. These needles are essential due to their unique need for precision, biocompatibility, and resistance to corrosion in delicate and critical surgical environments. The necessity of cardiovascular needles arises from the increasing prevalence of cardiovascular diseases, as well as the growing number of surgical interventions required globally, which stems from factors like aging populations and lifestyle diseases. The end-use scope primarily involves hospitals, specialty clinics, and ambulatory surgical centers. Key factors influencing market growth include advancing surgical techniques that necessitate more reliable and efficient tools, burgeoning healthcare infrastructure, and the increasing adoption of minimally invasive procedures, which require sophisticated needle technologies. Opportunities in this market lie in the development of needles that reduce surgery times and trauma, alongside innovations in material science for enhanced performance. The rise of robotic-assisted surgeries further boosts demand for specialized needles, representing an area ripe for innovation. However, challenges such as strict regulatory frameworks, high costs of advanced surgical needles, and their disposable nature limiting long-term usage profitability hinder market growth. A significant limitation is the variation in healthcare standards across regions, affecting universal adoption. Thus, innovative strategies include focusing on cost-effective production techniques, development of biodegradable or reusable needles, and expansion into emerging markets with customized offerings to overcome regional disparities. Furthermore, ongoing research into nano-materials and smart technologies presents a promising frontier for the fabrication of next-gen needles with embedded sensors for real-time feedback. The market remains fragmented but is marked by intense competition, requiring companies to stay agile and responsive to technology trends and end-user demands to capitalize on growth opportunities effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 83.17 million
Estimated Year [2024] USD 89.02 million
Forecast Year [2030] USD 134.59 million
CAGR (%) 7.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Needle Market

The Cardiovascular Needle Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing number of cardiovascular interventions worldwide
    • Growing geriatric population and rising prevalence of cardiovascular diseases
    • Increasing number of open heart surgeries
  • Market Restraints
    • Use of surgical staples instead of needles
  • Market Opportunities
    • Growing technology intervention including laser drilled cardiovascular needle
    • Rising R&D spending on medical instruments
  • Market Challenges
    • Risk of injuries to healthcare workers

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Needle Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Needle Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Needle Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Needle Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Needle Market

A detailed market share analysis in the Cardiovascular Needle Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Needle Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Needle Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Needle Market

A strategic analysis of the Cardiovascular Needle Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Needle Market, highlighting leading vendors and their innovative profiles. These include Aurolab, B. Braun Melsungen AG, Barber of Sheffield Ltd., Becton, Dickinson, and Company, CP Medical, Inc. by Theragenics Corporation, Delacroix-Chevalier, Johnson & Johnson Services, Inc., KLS Martin, L.P., MANI, Inc., Medline Industries, LP, Meril Life Sciences Pvt. Ltd., Quality Needles Pvt. Ltd., Rumex International Corporation Ltd., Scanlan International Inc., Sklar Surgical Instruments, Surtex Instruments Limited, Suturex & Renodex, Symmetry Surgical Inc., Teleflex Incorporated, and Wexler Surgical.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Needle Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cutting Needles and Round Bodied Needles.
  • Based on Usage, market is studied across Multiple Use Or Eyed Needles and Single Use Or Eyeless Needles.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals & Clinics, and Specialty Clinics.
  • Based on Application, market is studied across Cardiac Valve Procedures, Coronary Artery Bypass, Graft Surgery, Heart Transplant, and Open Heart Surgery.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of cardiovascular interventions worldwide
      • 5.1.1.2. Growing geriatric population and rising prevalence of cardiovascular diseases
      • 5.1.1.3. Increasing number of open heart surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Use of surgical staples instead of needles
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing technology intervention including laser drilled cardiovascular needle
      • 5.1.3.2. Rising R&D spending on medical instruments
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of injuries to healthcare workers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiovascular Needle Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cutting Needles
  • 6.3. Round Bodied Needles

7. Cardiovascular Needle Market, by Usage

  • 7.1. Introduction
  • 7.2. Multiple Use Or Eyed Needles
  • 7.3. Single Use Or Eyeless Needles

8. Cardiovascular Needle Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals & Clinics
  • 8.4. Specialty Clinics

9. Cardiovascular Needle Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiac Valve Procedures
  • 9.3. Coronary Artery Bypass
  • 9.4. Graft Surgery
  • 9.5. Heart Transplant
  • 9.6. Open Heart Surgery

10. Americas Cardiovascular Needle Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cardiovascular Needle Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cardiovascular Needle Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Aurolab
  • 2. B. Braun Melsungen AG
  • 3. Barber of Sheffield Ltd.
  • 4. Becton, Dickinson, and Company
  • 5. CP Medical, Inc. by Theragenics Corporation
  • 6. Delacroix-Chevalier
  • 7. Johnson & Johnson Services, Inc.
  • 8. KLS Martin, L.P.
  • 9. MANI, Inc.
  • 10. Medline Industries, LP
  • 11. Meril Life Sciences Pvt. Ltd.
  • 12. Quality Needles Pvt. Ltd.
  • 13. Rumex International Corporation Ltd.
  • 14. Scanlan International Inc.
  • 15. Sklar Surgical Instruments
  • 16. Surtex Instruments Limited
  • 17. Suturex & Renodex
  • 18. Symmetry Surgical Inc.
  • 19. Teleflex Incorporated
  • 20. Wexler Surgical

LIST OF FIGURES

  • FIGURE 1. CARDIOVASCULAR NEEDLE MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOVASCULAR NEEDLE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CARDIOVASCULAR NEEDLE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CARDIOVASCULAR NEEDLE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOVASCULAR NEEDLE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOVASCULAR NEEDLE MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CUTTING NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY ROUND BODIED NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MULTIPLE USE OR EYED NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SINGLE USE OR EYELESS NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CARDIAC VALVE PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CORONARY ARTERY BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY GRAFT SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY HEART TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY OPEN HEART SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CARDIOVASCULAR NEEDLE MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CARDIOVASCULAR NEEDLE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. CARDIOVASCULAR NEEDLE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. CARDIOVASCULAR NEEDLE MARKET, FPNV POSITIONING MATRIX, 2023